Design Therapeutics, Inc.DSGNNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank33
3Y CAGR-35.4%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-35.4%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.00-68.5%
20240.01-12.2%
20230.01-2.6%
20220.01+18.6%
20210.01-
20200.00+100.0%
2019-0.19-